15 min listen
Pharma Gets Creative in Suits Against New Medicare Law
FromOn The Merits
ratings:
Length:
18 minutes
Released:
Sep 12, 2023
Format:
Podcast episode
Description
The pharmaceutical industry is making some bold constitutional arguments in its attempts to overturn a new law allowing Medicare to negotiate directly with drug makers on prices.
The industry says the law, part of the Biden administration's Inflation Reduction Act, violates the Fifth, Eighth, and even First Amendment rights of companies like Merck, Johnson & Johnson, and AstraZeneca, among others.
On this episode of our weekly podcast, On The Merits, Celine Castronuovo and David Schultz look into why the drug makers are waging this uphill legal battle against Medicare negotiations and whether they'll ultimately succeed.
Do you have feedback on this episode of On The Merits? Give us a call and leave a voicemail at 703-341-3690.
The industry says the law, part of the Biden administration's Inflation Reduction Act, violates the Fifth, Eighth, and even First Amendment rights of companies like Merck, Johnson & Johnson, and AstraZeneca, among others.
On this episode of our weekly podcast, On The Merits, Celine Castronuovo and David Schultz look into why the drug makers are waging this uphill legal battle against Medicare negotiations and whether they'll ultimately succeed.
Do you have feedback on this episode of On The Merits? Give us a call and leave a voicemail at 703-341-3690.
Released:
Sep 12, 2023
Format:
Podcast episode
Titles in the series (100)
The Biggest Business of Law Stories of 2015: In this teaser episode of the Big Law Business po… by On The Merits